Dinoprostone vaginal insert for cervical ripening and labor induction: A meta-analysis

Citation
Eg. Hughes et al., Dinoprostone vaginal insert for cervical ripening and labor induction: A meta-analysis, OBSTET GYN, 97(5), 2001, pp. 847-855
Citations number
20
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
OBSTETRICS AND GYNECOLOGY
ISSN journal
00297844 → ACNP
Volume
97
Issue
5
Year of publication
2001
Part
2
Pages
847 - 855
Database
ISI
SICI code
0029-7844(200105)97:5<847:DVIFCR>2.0.ZU;2-D
Abstract
Objective: To compare dinoprostone 10 mg controlled-release vaginal insert with other forms of vaginal or cervical prostaglandin for cervical ripening . Data Sources: Literature search strategy included review of the Cochrane da tabase of randomized trials, on-line searching of MEDLINE, hand searching o f bibliographies, and contact with authors of relevant reports. Methods of Study Selection: Randomized trials were included if they compare d a dinoprostone slow-release vaginal insert with an alternative vaginal or cervical prostaglandin for cervical ripening and labor induction in women at term with singleton gestations. Primary end points were delivery by 24 h ours postinsertion, uterine hypertonus with fetal heart change, and cesarea n delivery rate. Study inclusion, validity assessment, and data extraction were carried out independently by two reviewers, and cross-checked for cons istency. Data were combined when appropriate, using the Mantel-Haenszel fix ed-effects method. Statistical heterogeneity was assessed using chi-square statistics. Tabulation, Integration, and Results: Nine relevant trials were identified, seven comparing the dinoprostone 10 mg vaginal insert with dinoprostone ge l and two with misoprostol. Five trials reported adequate methods for rando mization concealment. None were double blind. The likelihood of delivery by 24 hours was similar with the vaginal insert and alternatives: common odds ratio (OR) 0.80 (95% confidence interval [CI] 0.56, 1.15). Uterine hyperto nus with change in fetal heart and cesarean delivery rate were also similar : common OR 1.19 (95% CI 0.56, 2.54) and 0.78 (95% CI 0.56, 1.08), respecti vely. The secondary end points of mean time to delivery and delivery by 12 hours appeared to favor misoprostol-dinoprostone gel. However, data for the se end points were heterogeneous and their combination is therefore of limi ted value and potentially misleading. Conclusion: No clinically significant differences were identified between t he vaginal insert and alternatives used for cervical ripening at term. (C) 2001 by The American College of Obstetricians and Gynecologists.